Therefore CYMBALTA should not be administered in combination with potent inhibitors of CYP1A2 like fluvoxamine (see section 4.3).
Seetõttu ei tohi CYMBALTA’ t manustada koos tugevate CYP1A2 inhibiitoritega nagu fluvoksamiin (vt lõik 4. 3).